// App-Quantinova.ai

70 : Quality of Life in Patients with Active Non Radiographic Axial Spondyloarthritis After 16 Weeks of Golimumab Treatment

Researchers

Presenter

  • Sean Curtis

Principal Investigators

  • Maxime Dougados

  • Gina Bergman

  • Susan Huyck

  • Anjela Tzontcheva

  • Joachim Sieper

Medical Centers

  • University of Alberta, Edmonton, AB, Canada

  • Paris Descartes University, Paris, France

  • Brustzentrum Charite-Universitatsmedizin, Berlin, Germany

Locations

  • France

  • Canada

  • Germany

Companies

  • Merck & Co., Inc.

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Axial spondyloarthritis

  • Ankylosing spondylitis

  • Spondyloarthritis

  • Non-radiographic axial spondyloarthritis

Biomarkers

  • C reactive protein

Drug/Treatment

  • golimumab

Outcome

  • Unknown

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved